As a reliable inflammatory biomarker, CRP is strongly associated with the increased risk and severity of AKI in patients with acute myocardial infarction or group A streptococcal bacteremia (Cosentino et al., 2019; Li et al., 2023; Vilhonen et al., 2022). The gene discussed is CRP; the disease is acute kidney injury.